Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 4:25 pm Sale | 2024-12-31 | 13G | TherapeuticsMD, Inc. TXMD | Clearline Capital LP | 635,222 5.500% | -1,400 (-0.22%) | Filing History |
| 2024-11-12 4:40 pm Purchase | 2024-09-30 | 13G | TherapeuticsMD, Inc. TXMD | Clearline Capital LP | 636,622 5.520% | 636,622 (New Position) | Filing History |
| 2023-11-17 09:28 am Purchase | 2023-11-15 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 2,946,908 25.730% | 877,192 (+42.38%) | Filing History |
| 2023-06-30 08:29 am Purchase | 2023-06-28 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 2,069,716 19.570% | 347,763 (+20.20%) | Filing History |
| 2022-08-30 09:09 am Unchanged | 2022-08-23 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 1,721,953 18.270% | 0 (Unchanged) | Filing History |
| 2022-08-08 4:42 pm Purchase | 2022-08-04 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 1,721,953 18.270% | 1,721,953 (New Position) | Filing History |
| 2022-07-08 4:52 pm Purchase | 2022-06-30 | 13G | TherapeuticsMD, Inc. TXMD | BlackRock Inc. BLK | 122,138 1.400% | 122,138 (New Position) | Filing History |
| 2022-06-03 4:39 pm Purchase | 2022-05-31 | 13G | TherapeuticsMD, Inc. TXMD | Beryl Capital Management LLC | 126,229 1.500% | 126,229 (New Position) | Filing History |
| 2022-03-23 4:17 pm Purchase | 2022-03-23 | 13D | TherapeuticsMD, Inc. TXMD | SMITH ROBERT J | 462,066 5.380% | 263,292 (+132.46%) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | TherapeuticsMD, Inc. TXMD | PRICE T ROWE ASSOCIATES INC | 12,996 0.100% | -364,388 (-96.56%) | Filing History |
| 2022-01-31 5:49 pm Purchase | 2021-12-31 | 13G | TherapeuticsMD, Inc. TXMD | BlackRock Inc. BLK | 497,896 5.900% | 69,511 (+16.23%) | Filing History |
| 2021-07-07 2:02 pm Purchase | 2021-07-02 | 13G | TherapeuticsMD, Inc. TXMD | James E. Flynn | 413,256 4.900% | 413,256 (New Position) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | TherapeuticsMD, Inc. TXMD | PRICE T ROWE ASSOCIATES INC | 377,384 6.200% | -7,407 (-1.92%) | Filing History |
| 2021-02-10 11:57 am Sale | 2020-12-31 | 13G | TherapeuticsMD, Inc. TXMD | VANGUARD GROUP INC | 263,313 4.390% | -68,592 (-20.67%) | Filing History |
| 2021-02-08 10:33 am Sale | 2021-02-05 | 13G | TherapeuticsMD, Inc. TXMD | FMR LLC | 282,329 4.709% | -71,220 (-20.14%) | Filing History |
| 2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | TherapeuticsMD, Inc. TXMD | BlackRock Inc. BLK | 428,385 7.100% | 63,203 (+17.31%) | Filing History |
| 2020-12-09 11:54 am Sale | 2020-11-30 | 13G | TherapeuticsMD, Inc. TXMD | JPMORGAN CHASE & CO JPM | 261,589 4.300% | -132,772 (-33.67%) | Filing History |